Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Following a study conducted on etest? polymyxin b with 180 clinical strains (pseudomonas aeruginosa acinetobacter and enterobacteriaceae) an underestimation of mics has been observed for pseudomonas aeruginosa and acinetobacter species compared to those obtained using the broth micro-dilution (bmd) reference method. this has led to false susceptible results when the etest? polymyxin b results are interpreted using clsi breakpoints.